BCRX
BIOCRYST PHARM
Health Care·Biotechnology·UNITED STATES
$8.33
MCap $2.1B
as of 2026-06-09
Total
C1w
Fund
B1w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.09
Sentiment 35.6%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$8.33
Adaptive Mean
$8.31
+0.02 vs mean
Adaptive σ
0.12
MIDOS BB
$8.07 – $8.55
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+2.22
ROE
—
Z —
Rev Gr
7.5%
Z -0.24
EPS Gr
63.6%
Z +0.17
OPM Gr
1968.7%
Z +6.91
FCF Yld
17.1%
Z +1.06
EPS Surp
2283.0%
Z +4.59
EPS 3mo Δ
61.2%
Z +0.81
Fwd P/E
12.25
Z —
PEGY
0.19
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-3.70
Q6M
2.01
Q12M
-4.25
MA 30/100
1.048
Bullish (MA30 > MA100)
α (Jensen)
-0.3796
β (12M)
0.81
σ (12M)
0.447
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
100%
Q Percentile
20%
Divergence
+79.7
Tier
RELOAD — ACT
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
8.2
RS Pctl
62%
RS Decile
D7
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.